Max Robotics — Global Service Robot Directory + US Certification

About

Liam Masterson is a leading head and neck surgical oncologist whose research focuses on optimizing treatment for oropharyngeal squamous cell carcinoma (OPSCC), particularly in the context of the rising human papillomavirus (HPV)-associated epidemic. His major contributions center on comparing minimally invasive surgical approaches—such as transoral robotic surgery—against radiotherapy and chemoradiotherapy for small-volume and early-stage disease. In his highly cited 2016 paper (82 citations), Masterson demonstrated that minimally invasive surgery offers a viable alternative to radiation-based treatments for small-volume primary oropharyngeal carcinoma, potentially reducing long-term toxicity. He further advanced the field with his 2018 study (48 citations) exploring de-intensified adjuvant therapy following surgery for HPV-positive patients, aiming to maintain excellent oncologic outcomes while minimizing treatment-related morbidity. This work addresses a critical need: younger, HPV-positive patients often face decades of survivorship, making de-escalation strategies essential. Masterson’s research has directly influenced clinical trial design and treatment paradigms, helping to shift practice toward more personalized, less toxic care. His scholarship bridges surgical innovation and evidence-based oncology, making him a key voice in the ongoing effort to refine management of this increasingly common cancer.